Publications by authors named "Mathieu Vaillant"
Although uncommon, Epstein-Barr virus-related neurological disorders represent the seventh most frequent cause of infectious encephalitis in adults. The limited number of publications on EBV encephalitis mainly document isolated clinical cases. This study aimed to summarize published data on EBV encephalitis.
View Article and Find Full Text PDFArticle Synopsis
- - The study evaluates the effectiveness of TNF-α inhibitors as a steroid-sparing treatment for patients with central nervous system (CNS) sarcoidosis, monitoring their ability to minimize steroid use while avoiding worsening symptoms.
- - Among 23 patients analyzed, there was a significant reduction in the mean steroid dosage from 31.5 mg to 6.5 mg after starting TNF-α inhibitors, with 65% of patients achieving a dosage of less than 6 mg/day.
- - The findings indicate that TNF-α inhibitors can effectively manage CNS parenchymal sarcoidosis, leading to clinical improvements in many patients while reducing the reliance on steroids.
Importance: Risk factors associated with the severity of coronavirus disease 2019 (COVID-19) in patients with multiple sclerosis (MS) are unknown. Disease-modifying therapies (DMTs) may modify the risk of developing a severe COVID-19 infection, beside identified risk factors such as age and comorbidities.
Objective: To describe the clinical characteristics and outcomes in patients with MS and COVID-19 and identify factors associated with COVID-19 severity.
Objectives: Central neurological manifestations of rheumatoid arthritis (RA) like rheumatoid meningitis (RM) are rare, little known and have a high rate of morbi-mortality.
Methods: We described six cases of RM that were directly related to RA activity after exhaustive assessment.
Results: They were mainly women, aged of 50 to 69.
Introduction: Hepatitis E virus (HEV) infection has been reported to be associated with neurological disorders. However, the real prevalence of acute hepatitis E in those diseases is still unknown. We determined the prevalence of anti-HEV IgM antibody in a population with acute non-traumatic, non-metabolic, non-vascular neurological injury.
View Article and Find Full Text PDFImportance: Risk of developing progressive multifocal leukoencephalopathy (PML) is the major barrier to using natalizumab for patients with multiple sclerosis (MS). To date, the association of risk stratification with PML incidence has not been evaluated.
Objective: To describe the temporal evolution of PML incidence in France before and after introduction of risk minimization recommendations in 2013.
Objective: To evaluate the efficacy of resistance exercises in RA patients.
Methods: A systematic literature search was done using Pubmed, Embase and Cochrane databases through November 2009 and in abstracts presented at rheumatology scientific meetings over the past 3 years. Randomized controlled trials (RCTs) comparing resistance exercise based therapy with interventions without resistance exercise for the treatment of RA patients were included.